Inflammatory Bowel Diseases and Nephropathies: Exploring the Gut–Kidney Axis
Author Information
Author(s): de Sire Roberto, La Mantia Alessia, Bonacci Livio, Testa Anna, Guarino Alessia Dalila, Rispo Antonio, Nardone Olga Maria, Castiglione Fabiana
Primary Institution: University Federico II, Naples, Italy
Hypothesis
The study aims to elucidate the basis of IBD-related nephropathies, focusing on IgA nephropathy and the gut–kidney axis.
Conclusion
Renal involvement in IBD is often underestimated, but emerging research highlights the gut–kidney axis as a significant factor in nephropathy development.
Supporting Evidence
- Approximately 20–30% of patients with glomerulonephritis may progress to end-stage kidney disease if left untreated.
- Patients with inflammatory bowel disease show notable disparities in gut microbiota composition compared to healthy controls.
- Emerging evidence indicates that gut microbiota contributes to chronic kidney disease pathogenesis.
Takeaway
This study looks at how gut problems in people with inflammatory bowel disease can also affect their kidneys, especially in a condition called IgA nephropathy.
Methodology
The study is a narrative review that synthesizes existing research on the gut–kidney axis and its implications for IBD-related nephropathies.
Potential Biases
Potential biases may arise from the selective reporting of studies and the interpretation of existing data.
Limitations
The study relies on existing literature and may not include all recent findings or data.
Participant Demographics
The study discusses findings related to patients with inflammatory bowel disease and IgA nephropathy but does not provide specific demographic data.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website